Citations

Clear

16258 citation(s) found for "David, C S".

Statistical Evaluation of Internal and External Mass Calibration Laws Utilized in Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
Muddiman, David C. , Oberg, Ann L.

Mayo Clinic

Analytical Chemistry | April 14, 2005 | Volume: 77 | Issue: 8 | Pages: 2406-2414

10.1021/ac048258l | PMID 15828774 Get It

Mapping Sites of Protein Phosphorylation by Mass Spectrometry Utilizing a Chemical-Enzymatic Approach:  Characterization of Products from α-S1Casein Phosphopeptides
Muddiman, David C. , McCormick, Daniel , Holmes, Michael W.R. , Madden, Benjamin J.

Mayo Clinic

Journal of Proteome Research | April 11, 2005 | Volume: 4 | Issue: 2 | Pages: 424-434

10.1021/pr049804u | PMID 15822919 Get It

Exercise Single-Photon Emission Computed Tomography Provides Effective Risk Stratification of Elderly Men and Elderly Women
Valeti, Uma, Miller, Todd D., Hodge, David O. , Gibbons, Raymond J.

Mayo Clinic

Circulation | April 5, 2005 | Volume: 111 | Issue: 14 | Pages: 1771-1776

10.1161/01.cir.0000160862.36124.8e | PMID 15809375 Get It

Background— In a recent study, we reported that the Duke treadmill score was unable to effectively stratify elderly patients according to risk. The purpose of this study was to evaluate the prognostic value of exercise single-photon emission computed tomography (SPECT) in this same population and to examine results by gender. Methods and Results— A cohort of 247 elderly (age ≥75 years) patients (108 women, 139 men, age 77±3 years) who underwent exercise thallium-201 SPECT were followed up for a median duration of 6.4 years. SPECT variables were significantly associated with cardiac death: summed stress score (SSS) χ 2 =19.5, P <0.001; summed difference score χ 2 =12.3, P <0.001; increased lung uptake χ 2 =9.6, P =0.002; and left ventricular enlargement χ 2 =8.3, P =0.004. The Duke score was not significantly associated with cardiac death (χ 2 <1, P =NS). The SSS classified most patients as low risk (49%) or high risk (35%); the Duke score classified the majority (68%) as intermediate risk. Annual cardiac mortality rates for patients categorized by SSS as low risk and high risk were 0.8% and 5.8%, respectively. Cardiac survival rates according to SSS risk categories were significantly different for both women ( P =0.012) and men ( P =0.003). Conclusions— SPECT classified most elderly patients into clinically useful low- and high-risk categories and accurately predicted outcomes in both genders. If these results can be validated in future studies, exercise SPECT rather than standard treadmill testing may emerge as the initial noninvasive testing strategy in elderly patients who are able to exercise.
Primary Hyperparathyroidism in Pediatric Patients
Kollars, Josh, Zarroug, Abdalla E., Heerden, Jon van, Lteif, Aida, Stavlo, Penny, Suarez, Luis , Moir, Christopher R. , Ishitani, Michael B., Rodeberg, David A. , Kollars, Joshua P.

Mayo Clinic

Pediatrics | April 1, 2005 | Volume: 115 | Issue: 4 | Pages: 974-980

10.1542/peds.2004-0804 | PMID 15805373 Get It

Objective. Primary hyperparathyroidism (HPT) is unusual in children. We reviewed our experience with HPT to better characterize these children. Methods. The retrospective review of patients &lt;19 years old who underwent parathyroid resection for primary HPT from 1970 to 2000 was performed at a single institution.. Results. Fifty-two patients were identified. Median age was 16.8 years (range: 4–18.9) with a female-to-male ratio of 3:2. Eighty-five percent had an elevated parathyroid hormone (PTH) level, and 15% had an inappropriately normal PTH level during hypercalcemia. Serum calcium was elevated in all patients except for 2 with multiple endocrine neoplasma (MEN)-IIA and 1 with familial non-MEN HPT, but both had elevated PTH levels. Alkaline phosphatase levels were significantly higher in children with documented bone involvement. At presentation 41 patients (79%) were symptomatic and end-organ damage (nephrocalcinosis, nephrolithiasis, acute pancreatitis, or bone involvement) occurred in 23 patients (44%). Thirty-four patients (65%) had a single adenoma; hyperplasia was identified in 16 patients (27%), and of these cases, 57% occurred in patients diagnosed with MEN-I. Short-term complications included transient hypocalcemia in 29 patients (56%) and transient vocal cord paralysis in 2 patients (4%). Long-term complications were significant for permanent hypocalcemia in 2 patients (4%) and no recurrent laryngeal nerve injuries. No parathyroid abnormalities were identified during exploration in 4 (8%) children. Long-term follow-up was achieved in 98% of patients for a mean and median of 13 years. Resolution of hypercalcemia was achieved in 94% of cases. Conclusion. The diagnosis of primary HPT in pediatric patients is frequently delayed, is commonly symptomatic, and has significant morbidity. For children in whom HPT is suspected, evaluation of serum calcium and PTH levels is diagnostic in 100% of children. Parathyroid resection is effective at restoring normal serum calcium, has few complications, and is the treatment of choice for children with primary hyperparathyroidism.
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
Loegering, David A., Powell, Heather L., Flatten, Karen S., Arlander, Sonnet J.H., Dai, Nga T., Heldebrant, Michael P., Vroman, Benjamin T., Karp, Judith E. , Eyck, Cynthia J. Ten, Erlichman, Charles , Karnitz, Larry M., Mesa, Ruben A. , Smith, B. Douglas , Eyck, Cynthia Ten, Kaufmann, Scott H.

Mayo Clinic

Blood | March 23, 2005 | Volume: 106 | Issue: 1 | Pages: 318-327

10.1182/blood-2004-09-3523 | PMID 15784732 Get It

Previous studies demonstrated that ataxia telangiectasia mutated– and Rad3-related (ATR) kinase and its downstream target checkpoint kinase 1 (Chk1) facilitate survival of cells treated with nucleoside analogs and other replication inhibitors. Recent results also demonstrated that Chk1 is depleted when cells are treated with heat shock protein 90 (Hsp90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG). The present study examined the effects of 17-AAG and its major metabolite, 17-aminogeldanamycin (17-AG), on Chk1 levels and cellular responses to cytarabine in human acute myelogenous leukemia (AML) cell lines and clinical isolates. Cytarabine, at concentrations as low as 30 nM, caused activating phosphorylation of Chk1, loss of the phosphatase Cdc25A, and S-phase slowing. Conversely, treatment with 100 to 300 nM 17-AAG for 24 hours caused Chk1 depletion that was accompanied by diminished cytarabine-induced S-phase accumulation, decreased Cdc25A degradation, and enhanced cytotoxicity as measured by inhibition of colony formation and induction of apoptosis. Additional studies demonstrated that small inhibitory RNA (siRNA) depletion of Chk1 also sensitized cells to cytarabine, whereas disruption of the phosphatidylinositol 3-kinase (PI3k) signaling pathway, which is also blocked by Hsp90 inhibition, did not. Collectively, these results suggest that treatment with 17-AAG might represent a means of reversing checkpoint-mediated cytarabine resistance in AML.
Human Leukocyte Antigen-DQ8 Transgenic Mice: a Model To Examine the Toxicity of Aerosolized Staphylococcal Enterotoxin B
Roy, Chad J. , Warfield, Kelly L. , Welcher, Brent, Gonzales, Raoul, Larsen, Thomas , Hanson, Julie A., David, Chella S., Krakauer, Theresa, Bavari, Sina

Mayo Clinic

Infection and Immunity | March 22, 2005 | Volume: 73 | Issue: 4 | Pages: 2452-2460

10.1128/iai.73.4.2452-2460.2005 | PMID 15784591 Get It

ABSTRACTStaphylococcal enterotoxins (SEs) belong to a large group of bacterial exotoxins that cause severe immunopathologies, especially when delivered as an aerosol. SEs elicit the release of lethal amounts of cytokines by binding to major histocompatibility complex (MHC) class II and cross-linking susceptible T-cell receptors. Efforts to develop effective therapeutic strategies to protect against SEs delivered as an aerosol have been hampered by the lack of small animal models that consistently emulate human responses to these toxins. Here, we report that human leukocyte antigen-DQ8 (HLA-DQ8) transgenic (Tg) mice, but not littermate controls, succumbed to lethal shock induced by SEB aerosols without potentiation. Substantial amounts of perivascular edema and inflammatory infiltrates were noted in the lungs of Tg mice, similar to the pathology observed in nonhuman primates exposed by aerosol to SEB. Furthermore, the observed pathologies and lethal shock correlated with an upsurge in proinflammatory cytokine mRNA gene expression in the lungs and spleens, as well as with marked increases in the levels of proinflammatory circulating cytokines in the Tg mice. Unlike the case for littermate controls, telemetric evaluation showed significant hypothermia in Tg mice exposed to lethal doses of SEB. Taken together, these results show that this murine model will allow for the examination of therapeutics and vaccines developed specifically against SEB aerosol exposure and possibly other bacterial superantigens in the context of human MHC class II receptors.
Current Indications for the Use of The Artificial Genitourinary Sphincter and Management of It's Complications
Elliott, Daniel S. , Barrett, David M.

Mayo Clinic

The Scientific World JOURNAL | March 16, 2005 | Volume: 4 | Issue: No issue available | Pages: 114-127

10.1100/tsw.2004.57 | PMID 29861669 Get It

Leveling response factors in the electrospray ionization process using a heated capillary interface
Frahm, Jennifer L., Muddiman, David C. , Burke, Michael J.

Mayo Clinic

Journal of the American Society for Mass Spectrometry | March 11, 2005 | Volume: 16 | Issue: 5 | Pages: 772-778

10.1016/j.jasms.2005.02.002 | PMID 15862778 Get It

Myelofibrosis with Myeloid Metaplasia: New Developments in Pathogenesis and Treatment
Dingli, David , Tefferi, Ayalew , Mesa, Ruben A. , Dingli, David

Mayo Clinic

Internal Medicine | March 4, 2005 | Volume: 43 | Issue: 7 | Pages: 540-547

10.2169/internalmedicine.43.540 | PMID 15335177 Get It

THE EXTENT OF LYMPHADENECTOMY FOR pTXNO PROSTATE CANCER DOES NOT AFFECT PROSTATE CANCER OUTCOME IN THE PROSTATE SPECIFIC ANTIGEN ERA
DiMarco, David S., Zincke, Horst, Sebo, Thomas J., Slezak, Jeffrey M., Bergstralh, Erik J., Blute, Michael L.

Mayo Clinic

Journal of Urology | March 2, 2005 | Volume: 173 | Issue: 4 | Pages: 1121-1125

10.1097/01.ju.0000155533.93528.4c | PMID 15758719 Get It